91 results
Page 3 of 5
8-K
lfh6vo4i
5 Jun 23
Regulation FD Disclosure
6:08am
8-K
EX-99.1
15gjm3w hxv97
1 May 23
Day One Reports First Quarter 2023 Financial Results and Corporate Progress
9:01am
8-K
EX-99.2
e0vhtta
1 May 23
Day One Reports First Quarter 2023 Financial Results and Corporate Progress
9:01am
8-K
EX-99.1
fmy230u
20 Apr 23
Regulation FD Disclosure
6:08am
8-K
EX-99.2
jkufagrjo 4u
7 Nov 22
Day One Reports Third Quarter 2022 Financial Results and Corporate Progress
4:31pm
8-K
EX-99.1
avoqri
7 Nov 22
Day One Reports Third Quarter 2022 Financial Results and Corporate Progress
4:31pm
8-K
EX-99.2
35fc25sxb2kn6abgdo
12 Sep 22
Day One Appoints Garry Nicholson as Chairman of the Board of Directors
8:40am
8-K
EX-99.1
l5hm2b i692a4
12 Sep 22
Day One Appoints Garry Nicholson as Chairman of the Board of Directors
8:40am
8-K
EX-99.2
3t74gl0ab2 3tqcp
4 Aug 22
Day One Reports Second Quarter 2022 Financial Results and Corporate Progress
4:53pm
8-K
EX-99.1
de042 226j5gljt
4 Aug 22
Day One Reports Second Quarter 2022 Financial Results and Corporate Progress
4:53pm
8-K
EX-99.1
ffgubxh7b3z
24 Jun 22
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
EX-1.1
9ku17rj6
16 Jun 22
Day One Announces Pricing of Upsized Public Offering of Common Stock
7:33am
424B5
u1jd 1qnzog32bb
16 Jun 22
Prospectus supplement for primary offering
7:30am
424B5
rycdr
14 Jun 22
Prospectus supplement for primary offering
7:39am
8-K
EX-99.2
u7v4g4k6txq7s 3ciop0
13 Jun 22
Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma
6:24am
8-K
EX-99.1
aewncx ap5cjol3e
13 Jun 22
Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma
6:24am